New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
12:21 EDTPPC, ACRX, DG, CVS, TSN, TRLA, FDO, HSH, HZNP, Z, DLTR, ESRXOn The Fly: Midday Wrap
Stocks on Wall Street opened in negative territory and have remained there throughout the morning. The averages were narrowly lower in early trading, but picked up some downside momentum following the lower than expected pending home sales report. The market eventually found a level where it reversed and began drifting off its lows. By noon the averages returned to roughly where they sat prior to the homes data, as investors prepare for another heavy week of earnings, reports on GDP and labor market growth and a Federal Reserve decision on monetary stimulus. ECONOMIC EVENTS: In the U.S., the pending home sales index dropped 1.1% from the prior month to 102.7 in June, compared to expectations for it to have risen 0.5%. Markit's services PMI for July came in at 61.0 in the flash reading, which was flat with the prior reading and above the 59.8 consensus forecast. COMPANY NEWS: Dollar Tree (DLTR) agreed to acquire Family Dollar (FDO) in a cash and stock transaction estimated to be worth $74.50 per Family Dollar share. The transaction, which values Family Dollar at an enterprise value of about $9.2B and is expected to close by early 2015, was called the "best path forward" for Family Dollar by Nelson Peltz's Trian Fund, which disclosed that it will vote its 7.34% Family Dollar stake in favor of the buyout. Another company in the space, Dollar General (DG), which many investors thought would be the one to pursue a deal with Family Dollar, was initially lower after the deal announcement but Dollar General shares recovered to be up about 3% near noon, while Dollar Tree also climbed 3% and Family Dollar jumped 23%... Real estate website operator Zillow (Z) confirmed a deal to buy its rival, Trulia (TRLA), in a $3.5B, all-stock transactions. Reports about the deal first surfaced last week and Zillow fell 2.5% after the news, while Trulia climbed 12%. MAJOR MOVERS: Among the notable gainers was Tyson Foods (TSN), which rose more than 4% after reporting better than expected third quarter revenues, updating on its planned purchase of Hillshire (HSH) and agreeing to sell its poultry businesses in Mexico and Brazil to Pilgrim's Pride (PPC). Among the noteworthy losers was AcelRx (ACRX), which plunged 41% and was downgraded at Canaccord after the FDA issued a Complete Response Letter for the company's Zalviso drug. Also lower was Horizon Pharma (HZNP), which dropped 34% after it said it has been verbally notified that in August two pharmacy benefit managers, CVS Caremark (CVS) and Express Scripts (ESRX), expect to announce DUEXIS and VIMOVO will no longer be on their formularies and will be placed on their exclusion lists effective at the start of 2015. INDEXES: Near midday, the Dow was down 32.82, or 0.19%, to 16,927.75, the Nasdaq was down 18.96, or 0.43%, to 4,430.60, and the S&P 500 was down 4.56, or 0.23%, to 1,973.78.
News For DLTR;FDO;DG;Z;TRLA;ACRX;HZNP;TSN;PPC;HSH;CVS;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 30, 2015
13:48 EDTHZNPHyperion Therapeutics downgraded to Neutral from Buy at Roth Capital
Subscribe for More Information
12:22 EDTHZNPOn The Fly: Midday Wrap
Subscribe for More Information
11:49 EDTHZNPStreet Check: Hyperion bought after Brean noted takeout potential last month
Subscribe for More Information
11:02 EDTHZNPHyperion Therapeutics downgraded to Hold from Buy at Brean Capital
Brean Capital downgraded Hyperion Therapeutics (HPTX) citing the takeover by Horizon Pharma (HZNP). Brean views the buyout price as "reasonable and fair."
10:59 EDTESRX, CVSUnitedHealth in 'ring' with largest competitors after deal, say Piper Jaffray
Subscribe for More Information
10:12 EDTHZNPHigh option volume stocks
Subscribe for More Information
07:02 EDTHZNPHorizon Pharma to host conference call
Conference call to discuss the acquisition of Hyperion Therapeutics (HPTX) will be held on March 30 at 8 am. Webcast Link
06:04 EDTHZNPHorizon Pharma to acquire Hyperion Therapeutics for $46.00 per share
Subscribe for More Information
06:01 EDTHZNPHorizon Pharma to acquire Hyperion Therapeutics for $46.00 per share
Subscribe for More Information
March 25, 2015
16:37 EDTESRX, CVSSpecialists On Call names Hammad Shah as CEO
Subscribe for More Information
11:58 EDTTSN, PPCStephens food/agribusiness analyst holds analyst/industry conference call
Subscribe for More Information
11:45 EDTCVS, ESRXLeerink healthcare tech/pharma analysts hold analyst/industry conference call
Subscribe for More Information
08:57 EDTPPC, TSNJBS S.A. weighing IPO for U.S. unit, Bloomberg reports
The world’s biggest meat producer, JBS S.A. (JBSAY), is mulling plans for an initial public offering of its U.S. unit, according to Bloomberg, citing two people with direct knowledge of the matter. Other publicly traded companies in the meat production space include Hormel Foods (HRL), Pilgrim's Pride (PPC), Sanderson Farms (SAFM) and Tyson Foods (TSN). Reference Link
March 24, 2015
07:50 EDTTSNTyson Foods shares should be bought, says BB&T
Subscribe for More Information
March 20, 2015
15:28 EDTDGDollar General management to meet with Sterne Agee
Subscribe for More Information
15:04 EDTACRXAcelRx to reduce workforce by approximately 36%
Subscribe for More Information
15:02 EDTACRXAcelRx names Howard Rosen as interim CEO
AcelRx Pharmaceuticals (ACRX) announced the appointment of Howard Rosen as interim CEO of AcelRx, effective April 1. Rosen is a technically trained executive with over 25 years of success growing start-up and mid-size biopharmaceutical companies. Rosen previously held senior-level general management positions and functional roles in strategy, marketing, finance, business development, and research and development at Gilead Sciences (GILD) and ALZA Corporation. Rosen has served on the Board of Directors of AcelRx since 2008 and currently serves on the Board of Directors of Alcobra and several private biopharmaceutical companies.
March 17, 2015
16:58 EDTDGGIC Private Limited reports 5.02% passive stake in Dollar General
Subscribe for More Information
08:04 EDTESRXExpress Scripts has a conference call hosted by JPMorgan
JPMorgan Analyst Gill will host a conference call with CEO George Paz on March 18 at 11 am.
06:31 EDTCVSStudies find Gilead's hepatitis C drugs cost effective, Reuters says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use